Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prenatal cellular transplantation.

C T Albanese1, M R Harrison

  • 1University of California, Fetal Treatment Center, San Francisco 94143-0570, USA.

Seminars in Pediatric Surgery
|August 26, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human fetal surgery.

Surgical technology international·2015
Same author

Reversal of PSA progression on abiraterone acetate through the administration with food in men with metastatic castration-resistant prostate cancer.

Prostate cancer and prostatic diseases·2015
Same author

Requirement of retinoids for the expression of CD38 on human hematopoietic progenitors in vitro.

Cytotherapy·2010
Same author

Fetal spina bifida repair--current trends and prospects of intrauterine neurosurgery.

Fetal diagnosis and therapy·2008
Same author

Subcutaneous endoscopically assisted ligation (SEAL) of the internal ring for repair of inguinal hernias in children: report of a new technique and early results.

Surgical endoscopy·2007
Same author

Cropping systems for phytoremediation of phosphorus-enriched soils.

International journal of phytoremediation·2006
Same journal

The EXTra-uterine Environment for Neonatal Development (EXTEND) - future treatment for prematurity and potentially other congenital disease.

Seminars in pediatric surgery·2026
Same journal

Appendicitis as a model for pediatric surgical quality improvement and standardization.

Seminars in pediatric surgery·2026
Same journal

From FOB to PICU: military trauma systems that changed pediatrics.

Seminars in pediatric surgery·2026
Same journal

Long-term follow-up after surgery for congenital anomalies: A time to complication analysis.

Seminars in pediatric surgery·2026
Same journal

Radio-surgical decision-making in hepatoblastoma in the post-PHITT era: SIOPEL consensus recommendations.

Seminars in pediatric surgery·2026
Same journal

Seminars in pediatric sugery pediatric metabolic and bariatric surgery.

Seminars in pediatric surgery·2026
See all related articles

Fetal cellular transplantation offers a physiological approach for treating prenatal diagnoses like abnormal hemoglobin or enzyme defects. This method may also reduce the need for immunosuppression in postnatal organ transplants by inducing tolerance.

Area of Science:

  • Immunology
  • Developmental Biology
  • Transplantation Medicine

Background:

  • Fetal immunologic development offers unique opportunities for cellular therapies.
  • Prenatal diagnosis allows for early intervention strategies.
  • Cellular transplantation holds potential for treating genetic and immune disorders.

Purpose of the Study:

  • To review the scientific basis and experimental evidence for fetal cellular transplantation.
  • To explore the potential of fetal cellular transplantation in treating various prenatal conditions.
  • To assess the implications of cellular transplantation-induced tolerance for postnatal organ transplantation.

Main Methods:

  • Review of experimental data from small and large animal models spanning from the 1940s to the present.

Related Experiment Videos

  • Analysis of limited clinical case studies on prenatal cellular transplantation.
  • Main Results:

    • Fetal cellular transplantation is a physiologically sound strategy for correcting abnormal hemoglobin, immune cell, or enzyme defects diagnosed prenatally.
    • Cellular transplantation can potentially induce immune tolerance, minimizing the need for chronic immunosuppression in solid organ transplantation.
    • Experimental data supports the feasibility, while clinical experience remains limited.

    Conclusions:

    • Fetal cellular transplantation represents a promising therapeutic avenue for a range of prenatal conditions.
    • The induction of tolerance via cellular transplantation could revolutionize postnatal organ transplant protocols.
    • Further clinical research is warranted to fully establish the efficacy and safety of prenatal cellular transplantation.